Communicating data about the benefits and harms of treatment: a randomized trial.
about
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskLong term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trialsDecision boxes for clinicians to support evidence-based practice and shared decision making: the user experience.Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.Can an educational podcast improve the ability of parents of primary school children to assess the reliability of claims made about the benefits and harms of treatments: study protocol for a randomised controlled trialCommunicating with parents about vaccination: a framework for health professionals.Natural frequencies facilitate diagnostic inferences of managers.Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial.Natural frequencies improve Bayesian reasoning in simple and complex inference tasksHemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis.The Drug Facts Box: Improving the communication of prescription drug informationInfluence of medication risks and benefits on treatment preferences in older patients with multimorbidity.A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocolDefining and managing risk in asthma.The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011-2012 US pertussis epidemic.Translating Regenerative Biomaterials Into Clinical Practice.Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.Natural Frequencies Do Not Foster Public Understanding of Medical Test Results.The price of false beliefs: unrealistic expectations as a contributor to the health care crisis.Getting to better prescription drug information.Using comparison scenarios to improve prenatal risk communication.Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.For every complex problem, there is an answer that is clear, simple and wrong: and other aphorisms about medical statistical fallacies.Development and Validation of the Scientific Reasoning ScaleAssessment of Fracture Risk
P2860
Q26864640-83C7A702-F4A8-48B8-B7C5-42D40B96909BQ28543892-25C43B58-5A2B-43DE-AD8E-360ED0F6B4EDQ30530969-5681A850-D7F9-44A6-B9F9-6719F8C596EBQ30579901-D78AD7A4-67DA-4CED-AC6A-6A18B2D49F2BQ30835721-1CBC8A7B-F220-48F4-9917-ED6AD2B8C52AQ31098840-F39CDEBA-3EDC-43CC-8659-E7A3B8433D04Q35763832-3ED848C2-B901-4659-B7DD-5CB4BACE341DQ35837043-65D82390-4244-49DF-B3D7-9503C6498E58Q36117568-0833A4B9-6776-44B5-8E08-C66872EA3F5FQ36157899-1088AE7B-4A5B-4886-81E7-6D1CD82E4687Q36203714-8602EF12-8544-401F-94D4-F4455A0DA679Q37117584-DD5D5FE9-8E59-4FBC-AD55-1F9B4D071B74Q37608563-AC8AC3BC-5DE7-43C1-8183-1BA0E1D0AEA5Q38170584-A3975225-C79C-4D5B-8512-345D17A7928FQ38207697-C14F63EF-D8B6-4B50-B089-67565C694915Q38420571-BB4AE6BA-AD5C-4D3B-B0C5-D87B0EB7ADE8Q38522439-B1A9F4D1-9168-42D8-9A3E-B61C30812A5BQ38981425-69EB8F74-F83E-48E5-ACFC-BBCF4761B832Q39872627-0F197D4B-CC54-46ED-8CAB-C9088CC82EE4Q42344687-E5659E4F-48AA-48A0-8141-9D1F5E5E8985Q42364946-70356041-E9B1-45B7-A7F2-33AA2919CECDQ44275326-7B3845B6-DF60-4E07-AD0B-5AEF4B337F10Q44338782-1DE698C6-6256-4D2D-B287-3EB23932ED61Q48076910-28FC9E1D-0F69-4320-8A5B-2575D0A46A4BQ57697019-E164C4E5-1ECB-43A3-AE31-DC3E0EE118B4Q57711517-5B0BC9E6-979B-44DF-A006-DA3702DD3C2B
P2860
Communicating data about the benefits and harms of treatment: a randomized trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Communicating data about the benefits and harms of treatment: a randomized trial.
@ast
Communicating data about the benefits and harms of treatment: a randomized trial.
@en
type
label
Communicating data about the benefits and harms of treatment: a randomized trial.
@ast
Communicating data about the benefits and harms of treatment: a randomized trial.
@en
prefLabel
Communicating data about the benefits and harms of treatment: a randomized trial.
@ast
Communicating data about the benefits and harms of treatment: a randomized trial.
@en
P1476
Communicating data about the benefits and harms of treatment: a randomized trial.
@en
P2093
Lisa M Schwartz
Steven Woloshin
P356
10.7326/0003-4819-155-2-201107190-00004
P407
P577
2011-07-01T00:00:00Z